These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1680178)

  • 1. Disposition of hexobarbitone and antipyrine in DOCA-hypertensive rats.
    Ben-Zvi Z; Hreash F; Kaplanski J
    J Pharm Pharmacol; 1991 May; 43(5):349-52. PubMed ID: 1680178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of estrus cycle on drug metabolism in the rat.
    Brandstetter Y; Kaplanski J; Leibson V; Ben-Zvi Z
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):251-4. PubMed ID: 3582419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desoxycorticosterone on the activity of drug-metabolizing enzyme systems.
    Tantcheva L; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1989; 15(2):33-9. PubMed ID: 2801146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant status, lipid peroxidation, mixed function oxidase and UDP-glucuronyl transferase activities in livers from control and DOCA-salt hypertensive male Sprague Dawley rats.
    Nicod L; Rodriguez S; Letang JM; Viollon-Abadie C; Jacqueson A; Berthelot A; Richert L
    Mol Cell Biochem; 2000 Jan; 203(1-2):33-9. PubMed ID: 10724330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK; Ingall GB; Karler R
    Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual dimorphism and the effects of the X-linked Tfm locus on hexobarbitone metabolism and action in mice.
    King DK; Shapiro BH
    Br J Pharmacol; 1981 Sep; 74(1):97-104. PubMed ID: 7196788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcitonin on hepatic drug metabolism.
    Godinho AF; Cavalcante GJ; Machado MG; Faria TF; Gil TC; Coutinho RB; Garcia C
    Braz J Med Biol Res; 1988; 21(4):851-3. PubMed ID: 3240382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgenic repression of hexobarbitone metabolism and action in Crl:CD-1 (ICR)BR mice.
    Shapiro BH; Szczotka SM
    Br J Pharmacol; 1984 Jan; 81(1):49-54. PubMed ID: 6704585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of hexobarbital in primary cultures of rat hepatocytes maintains cytochrome P-450 levels and drug metabolizing enzyme activities.
    Kim HM; Ha JR; Park SK; Yang KH
    Drug Chem Toxicol; 1988; 11(1):29-41. PubMed ID: 3259924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Route- and dose-dependent pharmacokinetics of hexobarbitone in the rat: a re-evaluation of the use of sleeping times in metabolic studies.
    Van der Graaff M; Vermeulen NP; Breimer DD
    J Pharm Pharmacol; 1985 Aug; 37(8):550-4. PubMed ID: 2864415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
    Gadeholt G; Aarbakke J; Dybing E; Sjöblom M; Mørland J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS; Su PK
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women.
    Shedlofsky SI; Israel BC; Tosheva R; Blouin RA
    Br J Clin Pharmacol; 1997 Jun; 43(6):627-32. PubMed ID: 9205823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of cholestyramine treatment on hepatic mixed function oxidase activity.
    Bachmann K; Schwartz J; Forney R; Sherman G; Jauregui L
    Pharmacology; 1984; 29(3):128-41. PubMed ID: 6483959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-fenfluramine on rat liver drug-metabolizing enzymes.
    Conti I; Tridico RV; Duan L; Caccia S
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):163-74. PubMed ID: 2047564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes.
    Chung LW; Raymond G; Fox S
    J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the diethylamide of nicotinic acid (cordiamine) on the hydroxylating function of the liver].
    Bushma MI; Zavodnik LB; Lukienko PI
    Farmakol Toksikol; 1989; 52(4):56-9. PubMed ID: 2806530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.